Central nervous system: Notable developments in the management of primary and recurrent gliomas

Academic Article

Abstract

  • Over the past 30 years, the incidence of primary brain tumors has been increasing. Primary brain tumors are a heterogeneous group of central nervous system cancers with a wide range of outcomes and therapeutic strategies. As a result, prognostic features and molecular markers play a critical role in selecting treatment options for patients with brain tumors. At the NCCN 21st Annual Conference, Louis Burt Nabors, MD, reviewed the most appropriate adjuvant therapy for 3 types of brain tumors-primary low-grade gliomas, anaplastic oligodendrogliomas, and malignant gliomas-and shared supportive clinical trial data and NCCN recommendations.
  • Digital Object Identifier (doi)

    Author List

  • Nabors LB
  • Start Page

  • 681
  • End Page

  • 684
  • Volume

  • 14